Related Experiment Video

Updated: Aug 6, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Molecular and clinical correlates in iron overload associated with mutations in ferroportin

Ivana De Domenico1, Diane McVey Ward, Elizabeta Nemeth

  • 1Dipartimento di Scienze Microbiologiche Genetiche e Molecolari, Università di Messina, 98166 Messina, Italia.

Haematologica
|August 4, 2006
PubMed

Insights

Ferroportin (Fpn) mutations cause iron overload. Some Fpn mutants’ in vitro behavior doesn't match patient iron loading, suggesting complex disease mechanisms.

Area of Science:

  • Biochemistry
  • Genetics
  • Cell Biology

Background:

  • Mutations in ferroportin (Fpn), the sole cellular iron exporter, are linked to iron overload disorders.
  • Understanding the genotype-phenotype correlation of Fpn mutations is crucial for diagnosing and managing iron overload.

Purpose of the Study:

  • To investigate the in vitro functional consequences of specific ferroportin mutations.
  • To correlate the cellular behavior of Fpn mutants with observed patient phenotypes.

Main Methods:

  • Analysis of three distinct Fpn mutations (A77D, N174I, G80S) in cultured cells.
  • Assessment of Fpn mutant localization (cell surface vs. intracellular) and iron export activity.
  • Correlation of in vitro findings with clinical data from patients carrying these Fpn mutations.

Main Results:

  • FpnA77D mutant failed to localize to the cell surface, impairing iron export.
  • Fpn N174I mutant exhibited both intracellular and plasma membrane localization but lacked iron transport function.
  • FpnG80S mutant reached the cell surface and was transport-competent, yet patients presented with macrophage iron loading.

Conclusions:

  • The in vitro behavior of FpnA77D and Fpn N174I mutants aligns with observed iron overload phenotypes.
  • The FpnG80S mutant presents a discrepancy between in vitro function and patient phenotype, highlighting complexities in Fpn-mediated iron transport.
  • Further research is needed to elucidate mechanisms for Fpn mutants where in vitro assays do not fully predict clinical presentation.

More Related Videos

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron05:36

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...